YILI(SH:600887) 2 1 Shi Ji Jing Ji Bao Dao·2025-09-06 15:00Core Viewpoint - The competition in China's infant formula market is intensifying, with both Yili and Feihe claiming the top position based on different metrics [1][2]. Group 1: Market Positioning - Yili claims the overall market leader position in infant formula, including both cow and goat milk formulas, with a market share of 18.1%, up by 1.3 percentage points year-on-year [2]. - Feihe emphasizes its position as the leading single brand in the infant formula market, maintaining this status for six consecutive years [1][3]. - Yili's revenue from milk powder and dairy products grew by 14.26% year-on-year to 16.578 billion yuan, with infant formula sales showing double-digit growth [2]. Group 2: Company Performance - Feihe's revenue declined by 9.36% to 9.151 billion yuan in the first half of the year [3]. - Yili's acquisition of Ausnutria Dairy has contributed to its sales figures, but the actual impact of Ausnutria's sales on Yili's performance is less significant than anticipated, as Ausnutria's core goat milk brand sales fell by 8.9% to 1.38 billion yuan [4][5]. - The sales decline of Feihe has highlighted the competitive landscape, with both companies having a narrow market share gap [6]. Group 3: Market Trends - The infant formula market in China may face contraction due to a significant decline in marriage registrations, indicating a potential decrease in newborn numbers [7]. - Despite challenges, the infant formula market remains a lucrative sector, with high-end products dominating, driven by increased consumer spending on children [9]. - Domestic dairy companies are well-positioned to benefit from this consumption upgrade, with Yili and Feihe having superior milk sources compared to EU standards [11].